SLC18A2 and COVID-19: Our results showed that SARS-CoV-2 infection did not affect the expression of DBH and VMAT2, but elevated, however, the mRNA levels of MAOA and MAOB in infected cells and in the whole blood samples of hospitalized COVID-19 patients.